X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. DATSONS LABS UNICHEM LAB/
DR. DATSONS LABS
 
P/E (TTM) x 23.8 -10.9 - View Chart
P/BV x 2.3 0.2 1,386.5% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 UNICHEM LAB   DR. DATSONS LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
DR. DATSONS LABS
Mar-14
UNICHEM LAB/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs320126 254.7%   
Low Rs22131 715.2%   
Sales per share (Unadj.) Rs167.2133.0 125.7%  
Earnings per share (Unadj.) Rs12.00.2 7,887.7%  
Cash flow per share (Unadj.) Rs16.96.6 256.2%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs117.0128.8 90.9%  
Shares outstanding (eoy) m90.8831.66 287.0%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x1.60.6 274.9%   
Avg P/E ratio x22.6516.1 4.4%  
P/CF ratio (eoy) x16.011.8 134.9%  
Price / Book Value ratio x2.30.6 380.3%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m24,5782,477 992.1%   
No. of employees `0005.2NA-   
Total wages/salary Rs m2,48756 4,441.8%   
Avg. sales/employee Rs Th2,928.3NM-  
Avg. wages/employee Rs Th479.4NM-  
Avg. net profit/employee Rs Th209.4NM-  
INCOME DATA
Net Sales Rs m15,1954,211 360.9%  
Other income Rs m11079 140.0%   
Total revenues Rs m15,3054,289 356.8%   
Gross profit Rs m1,788569 314.4%  
Depreciation Rs m452204 221.0%   
Interest Rs m34430 7.8%   
Profit before tax Rs m1,41313 11,122.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3266 5,341.0%   
Profit after tax Rs m1,0875 22,641.7%  
Gross profit margin %11.813.5 87.1%  
Effective tax rate %23.148.0 48.0%   
Net profit margin %7.20.1 6,273.9%  
BALANCE SHEET DATA
Current assets Rs m6,4266,852 93.8%   
Current liabilities Rs m3,9176,711 58.4%   
Net working cap to sales %16.53.3 493.0%  
Current ratio x1.61.0 160.7%  
Inventory Days Days68161 42.1%  
Debtors Days Days77318 24.2%  
Net fixed assets Rs m7,4103,673 201.7%   
Share capital Rs m182317 57.4%   
"Free" reserves Rs m10,4543,761 278.0%   
Net worth Rs m10,6364,078 260.9%   
Long term debt Rs m41,671 0.3%   
Total assets Rs m15,25812,633 120.8%  
Interest coverage x42.91.0 4,168.6%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x1.00.3 298.8%   
Return on assets %7.33.4 213.3%  
Return on equity %10.20.1 8,679.9%  
Return on capital %13.67.7 177.1%  
Exports to sales %24.122.9 105.4%   
Imports to sales %4.914.3 34.6%   
Exports (fob) Rs m3,666964 380.3%   
Imports (cif) Rs m752602 124.9%   
Fx inflow Rs m5,298964 549.6%   
Fx outflow Rs m0607 0.0%   
Net fx Rs m5,298357 1,484.6%   
CASH FLOW
From Operations Rs m6831,345 50.8%  
From Investments Rs m-1,316-2,256 58.3%  
From Financial Activity Rs m592-1,200 -49.4%  
Net Cashflow Rs m-40-2,111 1.9%  

Share Holding

Indian Promoters % 50.1 4.5 1,106.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 1.4 222.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 94.1 33.7%  
Shareholders   20,176 20,807 97.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


May 21, 2018 03:35 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS